Doug Drysdale (@insidepharma) — Fintech / payments on X (Twitter)

Doug Drysdale is a Fintech / payments creator on X (Twitter) in the 2K–3K follower range, publishing for Biopharma executives, operators and strategic advisors focused on drug commercialization, M&A and capital strategy, based in United States. Profile last checked 2026-07-03.

| Field | Value |

| --- | --- |

| Platform | X (Twitter) |

| Handle | @insidepharma |

| Followers | 2K–3K |

| Category | Software · Fintech / payments |

| Market | United States |

Profile bio

Biopharma Operator & Strategic Advisor / Founder, Katogen / Board Member / PubCo CEO / M&A, Capital Strategy / Read My Newsletter: https://t.co/CISSuxuCBe

What this creator posts about, and who reads it

Audience: Biopharma executives, operators and strategic advisors focused on drug commercialization, M&A and capital strategy

Audience read from this creator’s own recent posts, not from platform-declared categories. It is our reading, and it can be wrong.

Recent content samples

https://t.co/Op14cg2Zvc

A migraine drug that works is worth nothing if the patient stops taking it. The CGRP class taught the field a lesson most people still have not absorbed. Eight products approved since 2018. First new prevention…

See the original post on X (Twitter)

Where this creator sits in the wider pool

Koinon Link indexes X (Twitter) creators in Software with grade, authenticity and contactability broken down — see the X (Twitter) × Software breakdown, or the Creator Index Report for the whole index.

This page lists public profile information only. It carries no contact details and no authenticity score. If you are Doug Drysdale and want this page removed, request removal.